MetLife Investment Management’s Synthorx, Inc. Common Stock THOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4,415
Closed -$309K 2361
2019
Q4
$309K Buy
+4,415
New +$126K ﹤0.01% 1729

MetLife Investment Management's THOR Position: Q1 2020 in Review

MetLife Investment Management sold out of Synthorx, Inc. Common Stock (THOR) in Q1 2020, closing a stake of 4,415 shares — an estimated $309K sold.

MetLife Investment Management first reported a position in THOR in Q4 2019 and held it in 1 quarter. The position peaked at $309K in Q4 2019. 0 funds tracked by Wall St. Rank hold THOR as of Q1 2020.

  • MetLife Investment Management reported no remaining Synthorx, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • MetLife Investment Management sold 4,415 Synthorx, Inc. Common Stock shares in Q1 2020, an estimated $309K.
  • MetLife Investment Management first reported a position in Synthorx, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • MetLife Investment Management's Synthorx, Inc. Common Stock position peaked at $309K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Synthorx, Inc. Common Stock as of Q1 2020.

Based on MetLife Investment Management's 13F filing for Q1 2020, filed 15 May 2020.